$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Conjugation of polymer to colony stimulating factor-1 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C08L-089/00
  • C07G-007/00
  • A61K-037/02
출원번호 US-0146275 (1988-01-20)
발명자 / 주소
  • Shadle Paula J. (Richmond CA) Koths Kirston E. (El Cerrito CA) Moreland Margaret (Berkeley CA) Katre Nandini (El Cerrito CA)
출원인 / 주소
  • Cetus Corporation (Emeryville CA 02)
인용정보 피인용 횟수 : 180  인용 특허 : 17

초록

A biologically active CSF-1 protein is selectively conjugated via certain amino acid residues or carbohydrate moieties to a water-soluble polymer selected from polyethylene glycol or polypropylene glycol homopolymers, polyoxyethylated polyols, or polyvinyl alcohol. The resulting conjugated CSF-1 is

대표청구항

A biologically active composition comprising a protein that stimulates the formation of primarily macrophage colonies in the in vitro colony stimulating factor-1 (CSF-1) assay, which protein is covalently conjugated to a water-soluble polymer selected from the group consisting of polyethylene or pol

이 특허에 인용된 특허 (17)

  1. Lee Weng Y. (Winnipeg CAX) Sehon Alec (Winnipeg CAX), Allergen-containing substances.
  2. Iwashita Yuji (Kawasaki JPX) Ajisaka Katsumi (Yokohama JPX), Blood substitute containing modified hemoglobin.
  3. Mitra Gautam (Kensington CA), Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer.
  4. Green Joseph (London EN) Cawthorne Michael Anthony (Horsham EN), Fibrinolytic compositions.
  5. Yamamura Yuichi (Takarazuka JPX) Kishimoto Tadamitsu (Tondabayashi JPX) Nakai Satoru (Tokushima JPX) Hirai Yoshikatsu (Tokushima JPX), Human cultured cell line.
  6. Nicolson Margery (Pacific Palisades CA), Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1.
  7. Hiratani Hajime (Sennan JPX), Long-acting composition.
  8. Mosbach Klaus H. (Furulund SEX) Nilsson Kurt G. I. (Lund SEX), Method of covalently binding biologically active organic substances to polymeric substances.
  9. Funakoshi Satoshi (Katano JPX) Morimoto Kazuo (Fukuchiyama JPX) Kuboyama Morio (Tokyo JPX) Yanai Nobuya (Tokyo JPX) Yamada Muneo (Kawasaki JPX) Yokota Hajime (Tokyo JPX), Method of preparation of human urine origin colony-stimulating factor and kallikrein.
  10. Royer Garfield P. (Worthington OH), Modifying enzymes with polyethylene glycol and product produced thereby.
  11. Davis Frank F. (19 Farmingdale Rd. East Brunswick NJ 08816) Van Es Theodorus (313 Overbrook Rd. Piscataway NJ 08854) Palczuk Nicholas C. (45 W. Franklin St. Bound Brook NJ 08805), Non-immunogenic polypeptides.
  12. Lee Weng Y. (95 Rochester Pl. Winnipeg CAX) Sehon Alec (695 Academy Rd. Winnipeg CAX R3N OE8), Penicillin-polyvinyl alcohol conjugate and process of preparation.
  13. Bayer Ernst (Tubingen DT) Mutter Manfred (Tubingen DT), Polyalkylene glycols used for the preparation of peptides.
  14. Sugimoto Kaname (Okayama JPX), Process for the production of human colony-stimulating factor.
  15. Schneider ; Michel, Reversibly precipitable immobilized enzyme complex and a method for its use.
  16. Katre Nandini (El Cerrito CA) Knauf Michael J. (Oakland CA), Solubilization of proteins for pharmaceutical compositions using polymer conjugation.
  17. Lee Weng Y. (99 Silver Ridge Rise NW. Calgary ; Alberta CAX T3B 4P6) Sehon Alec (695 Academy Rd. Winnipeg ; Manitoba CAX R3N 0E8), Suppression of reaginic antibodies to drugs employing polyvinyl alcohol as carrier therefor.

이 특허를 인용한 특허 (180)

  1. Qiu, Yongchang; Wang, Jack H.; Hewick, Rodney M., Acid-labile isotope-coded extractant (ALICE) and its use in quantitative mass spectrometric analysis of protein mixtures.
  2. Qiu,Yongchang; Wang,Jack H.; Hewick,Rodney M., Acid-labile isotope-coded extractant (ALICE) and its use in quantitative mass spectrometric analysis of protein mixtures.
  3. Sehl, Louis C.; Trollsas, Olof Mikael; Wallace, Donald G.; Toman, David; DeLustro, Frank A.; Schroeder, Jacqueline A.; Chu, George H., Adhesive tissue repair patch.
  4. Sehl, Louis C.; Trollsas, Olof Mikael; Wallace, Donald G.; Toman, David; DeLustro, Frank A.; Schroeder, Jacqueline A.; Chu, George H., Adhesive tissue repair patch and collagen sheets.
  5. Sherman, Merry R.; Saifer, Mark G. P.; Williams, L. David, Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates.
  6. Xu, Wenfeng; Kindsvogel, Wayne R.; Chandrasekher, Yasmin A.; Dillon, Stacey R.; Lehner, Joyce M.; Siadak, Anthony W.; Sivakumar, Pallavur V.; Moore, Margaret Dow, Anti-IL-22RA antibodies and binding partners and methods of using in inflammation.
  7. Xu, Wenfeng; Kindsvogel, Wayne R.; Chandrasekher, Yasmin A.; Dillon, Stacey R.; Lehner, Joyce M.; Siadak, Anthony W.; Sivakumar, Pallavur V.; Moore, Margaret Dow, Anti-IL-22RA antibodies and binding partners and methods of using in inflammation.
  8. Xu, Wenfeng; Kindsvogel, Wayne; Chandrasekher, Yasmin A.; Dillon, Stacey R.; Lehner, Joyce M.; Siadak, Anthony W.; Sivakumar, Pallavur V.; Moore, Margaret D., Anti-IL-22RA antibodies and binding partners and methods of using in inflammation.
  9. Gentz, Reiner L.; Ebner, Reinhard; Yu, Guo Liang; Ruben, Steven M.; Ni, Jian; Feng, Ping, Antibodies to tumor necrosis factor receptors 6α and 6β.
  10. DeFrees, Shawn; Wang, Zhi-Guang, Antibody toxin conjugates.
  11. Walsh,Scott M.; Shah,Anjali G.; Mond,James J.; Lees,Andrew; Drabick,Joseph J., Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol.
  12. Rhee,Woonza M.; DeLustro,Frank A.; Berg,Richard A., Biocompatible crosslinked composition.
  13. Jung, Yuni; Ho, Seong-Hyun; Park, Myung-Ok; Kim, Myoung-Suk, Biopolymer conjugates comprising an interleukin-11 analog.
  14. DeFrees, Shawn, Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1].
  15. DeFrees, Shawn, Branched water-soluble polymers and their conjugates.
  16. DeFrees, Shawn, Branched water-soluble polymers and their conjugates.
  17. Gegg, Jr., Colin V.; Johnson, Eileen J.; Miranda, Leslie P.; Walker, Kenneth W.; Holder, Jerry Ryan; Wright, Marie E.; D'Amico, Derin C., CGRP peptide antagonists and conjugates.
  18. Ishikawa Rika,JPX ; Okada Yuji,JPX ; Kakitani Makoto,JPX, Chemically-modified G-CSF.
  19. Ishikawa Rika,JPX ; Okada Yuji,JPX ; Kakitani Makoto,JPX, Chemically-modified G-CSF.
  20. Salcedo,Theodora W.; Patel,Vikram P.; Nibbs,Robert John Benjamin; Graham,Gerard John, Chemokine β-7 variants.
  21. Bendele Alison M. ; Sennello Regina M. ; Edwards III Carl K., Combination therapy using a TNF binding protein for treating TNF-mediated diseases.
  22. Rhee, Woonza M.; DeLustro, Frank A.; Berg, Richard A., Composition for administration of a biologically active compound.
  23. Walker, Kenneth W.; Gegg, Jr., Colin V., Compositions and methods for producing bioactive fusion proteins.
  24. DeFrees, Shawn, Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants.
  25. Daniloff, George Y.; Sehl, Louis C.; Trollsas, Olof Mikael; Schroeder, Jacqueline A.; Gravett, David M.; Toleikis, Philip M., Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
  26. Daniloff, George Y.; Sehl, Louis C.; Trollsas, Olof Mikael; Schroeder, Jacqueline A.; Gravett, David M.; Toleikis, Philip M., Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
  27. Daniloff, George Y.; Sehl, Louis C.; Trollsas, Olof Mikael; Schroeder, Jacqueline; Gravett, David M.; Toleikis, Philip M., Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
  28. Olof Mikael Trollsas ; Donald G. Wallace ; Frank A. DeLustro, Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
  29. Sehl, Louis C.; Trollsas, Olof Mikael; Wallace, Donald G.; Toman, David; DeLustro, Frank A.; Schroeder, Jacqueline A.; Chu, George H., Compositions and systems for forming crosslinked biomaterials and methods of preparation of use.
  30. Bolt, Gert; Vandahl, Brian Berg Stidsen; Thim, Lars; Stennicke, Henning Ralf; Steenstrup, Thomas Dock; DeFrees, Shawn, Conjugated factor VIII molecules.
  31. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V.; Khare, Taruna Arora; Adler, Beverly S.; Martin, Francis H., Conjugated toxin peptide therapeutic agents.
  32. Eichner, Wolfram; Schimmel, Martin; Hacket, Frank; Kraus, Elmar; Zander, Norbert; Frank, Ronald; Conradt, Harald; Langer, Klaus; Orlando, Michele; Sommermeyer, Klaus, Conjugates of hydroxyalkyl starch and a protein.
  33. Eichner, Wolfram; Schimmel, Martin; Hacket, Frank; Kraus, Elmar; Zander, Norbert; Frank, Ronald; Conradt, Harald; Langer, Klaus; Orlando, Michele; Sommermeyer, Klaus, Conjugates of hydroxyalkyl starch and a protein.
  34. Eichner, Wolfram; Orlando, Michele; Zander, Norbert; Conradt, Harald S.; Hacket, Frank; Langer, Klaus; Frank, Ronald, Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination.
  35. Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Jungheinrich, Cornelius; Scharpf, Roland; Lutterbeck, Katharina; Hemberger, Jurgen; Orlando, Michele, Conjugates of hydroxyalkyl starch and an active agent.
  36. Orlando, Michele; Hemberger, Jurgen; Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Lutterbeck, Katharina; Jungheinrich, Cornelius; Scharpf, Roland, Coupling low-molecular substances to a modified polysaccharide.
  37. Hemberger, Jurgen; Orlando, Michele; Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Lutterbeck, Katharina; Jungheinrich, Cornelius; Scharpf, Roland, Coupling proteins to a modified polysaccharide.
  38. Hemberger, Jurgen; Orlando, Michele; Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Lutterbeck, Katharina; Jungheinrich, Cornelius; Scharpf, Roland, Coupling proteins to a modified polysaccharide.
  39. Rhee, Woonza M.; DeLustro, Frank A.; Berg, Richard A., Cross-linked polymer compositions and methods for their use.
  40. Rhee,Woonza M.; DeLustro,Frank A.; Berg,Richard A., Crosslinked polymer compositions.
  41. Rhee Woonza M. ; DeLustro Frank A. ; Berg Richard A., Crosslinked polymer compositions and methods for their use.
  42. Rhee Woonza M. ; DeLustro Frank A. ; Berg Richard A., Crosslinked polymer compositions and methods for their use.
  43. Ladner Martha B. ; Van Arsdell Janelle N. ; Martin George A. ; Kawasaki Ernest S. ; Coyne Mazie Yee ; Halenbeck Robert F. ; Koths Kirston E., DNA encoding N.gradient.2 CSF-1 (short form) and carboxy truncated fragment thereof.
  44. Ladner Martha B. ; Van Arsdell Janelle N. ; Martin George A. ; Kawasaki Ernest S. ; Coyne Mazie Yee ; Halenbeck Robert F. ; Koths Kirston E., DNA encoding NV2 (long form) and carboxy truncated fragments thereof.
  45. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V., DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression.
  46. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V.; Arora Khare, Taruna; Adler, Beverly S.; Martin, Francis H., DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression.
  47. Zsebo Krisztina M. ; Bosselman Robert A. ; Suggs Sidney V. ; Martin Francis H., DNA encoding stem cell factor.
  48. Zsebo Krisztina M. ; Bosselman Robert A. ; Suggs Sidney V. ; Martin Francis H., DNS encoding stem cell factor.
  49. Gravett, David M.; Takacs-Cox, Aniko; Toleikis, Philip M.; Maiti, Arpita; Embree, Leanne, Drug delivery from rapid gelling polymer composition.
  50. Kokai Kun, John F.; Adams, Julie M.; Mond, James J.; Walsh, Scott M.; Shah, Anjali G.; Chanturiya, Tanya I., Enzyme disruption of bacterial biofilms.
  51. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Bowe, Caryn; Hakes, David James; Chen, Xi, Erythropoietin: remodeling and glycoconjugation of erythropoietin.
  52. DeFrees, Shawn; Zopf, David; Bayer, Robert; Bowe, Caryn; Hakes, David; Chen, Xi, Factor VII: remodeling and glycoconjugation of Factor VII.
  53. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Bowe, Caryn; Hakes, David James; Chen, Xi, Factor VIII: remodeling and glycoconjugation of factor VIII.
  54. DeFrees, Shawn; Bayer, Robert J.; Zopf, David A., Glycopegylated erythropoietin.
  55. DeFrees, Shawn; Zopf, David A.; Bowe, Caryn Lang, Glycopegylated erythropoietin.
  56. DeFrees, Shawn; Bayer, Robert J.; Zopf, David A.; Kang, Jichao; Willett, Walter Scott, Glycopegylated erythropoietin formulations.
  57. DeFrees, Shawn; Bayer, Robert J.; Bowe, Caryn L.; Panneerselvam, Krishnasamy, Glycopegylated factor IX.
  58. DeFrees, Shawn; Bayer, Robert J.; Bowe, Caryn; Paneerselvam, Krishnasamy, Glycopegylated factor IX.
  59. DeFrees, Shawn; Bayer, Robert J.; Bowe, Caryn; Panneer-Selvam, Krishnasamy, Glycopegylated factor IX.
  60. DeFrees, Shawn; Clausen, Henrik; Zopf, David A.; Bowe, Caryn; Taudte, Susann; Felo, Michael; Willett, Walter S., Glycopegylated granulocyte colony stimulating factor.
  61. DeFrees, Shawn; Zopf, David A.; Clausen, Henrik; Xing, Ruye, Glycopegylated interferon α.
  62. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Hakes, David James; Bowe, Caryn L.; Chen, Xi, Glycopegylation methods and proteins/peptides produced by the methods.
  63. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Hakes, David James; Bowe, Caryn; Chen, Xi, Glycopegylation methods and proteins/peptides produced by the methods.
  64. DeFrees, Shawn, Glycosylation of peptides via O-linked glycosylation sequences.
  65. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Bowe, Caryn; Hakes, David James; Chen, Xi, Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF.
  66. Conradt, Harald S.; Grabenhorst, Eckart; Nimtz, Manfred; Zander, Norbert; Frank, Ronald; Eichner, Wolfram, Hasylated polypeptides.
  67. Obermeier Rainer (Hattersheim DEX) Ludwig Jurgen (Brachttal DEX) Tripier Dominique (Eppstein DEX) Hropot Max (Florsheim DEX), Hirudin derivatives and a process for their preparation.
  68. Boime Irving, Hormone analogs with multiple CTP extensions.
  69. Theodora W. Salcedo ; Vikram P. Patel ; Robert John Benjamin Nibbs GB; Gerard John Graham GB, Human chemokine .beta.-7 deletion and substitution proteins.
  70. Zander, Norbert; Conradt, Harald S.; Eichner, Wolfram, Hydroxyalkyl starch derivatives.
  71. Zander, Norbert; Conradt, Harald; Eichner, Wolfram, Hydroxyalkyl starch derivatives.
  72. Hacket, Frank; Hey, Thomas; Hauschild, Franziska; Knoller, Helmut; Schimmel, Martin; Sommermeyer, Klaus, Hydroxyalkyl starch derivatives and process for their preparation.
  73. Kanegasaki, Shiro; Tamatani, Takuya, Immunopotentiating agent.
  74. Whitty, Adrian; Runkel, Laura; Brickelmaier, Margot; Hochman, Paula, Interferon-beta-1a-immunoglobulin fusion proteins and uses.
  75. Kambadur, Ravi; Sharma, Mridula; Senna Salerno De Moura, Monica; Berry, Carole J.; Siriett, Victoria; Bower, Robert Syndecombe; Nicholas, Gina Diane; McFarlane, Craig Desmond, Isolated polypeptides and methods of improving muscle strength.
  76. Daniloff, George Y.; Ngo, Michael Huy; Trollsas, Olof Mikael; Gravett, David M.; Toleikis, Philip M., Kit for multifunctional compounds forming crosslinked biomaterials.
  77. Hinderer, Walter; Scheckermann, Christian, Liquid formulation of G-CSF conjugate.
  78. Zsebo Krisztina M. ; Bosselman Robert A. ; Suggs Sidney V. ; Martin Francis H., Method for enhancing the effciency of gene transfer with stem cell factor (SCF) polypeptide.
  79. Zsebo, Krisztina M.; Bosselman, Robert A.; Suggs, Sidney V.; Martin, Francis H., Method for increasing hematopoietic progenitor cells by stem cell factor.
  80. Zsebo Krisztina M. ; Bosselman Robert A. ; Suggs Sidney V. ; Martin Francis H., Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides.
  81. Rhee, Woonza M.; DeLustro, Frank A.; Berg, Richard A., Method for preventing the formation of adhesions following surgery or injury.
  82. Sherman, Merry R.; Saifer, Mark G. P.; Williams, L. David; Hershfield, Michael S.; Kelly, Susan J., Method for purifying urate oxidase tetramers and octamers.
  83. Rhee, Woonza M.; DeLustro, Frank A.; Berg, Richard A., Method for treating or inhibiting the formation of adhesions following surgery or injury.
  84. Rhee Woonza M. ; DeLustro Frank A. ; Berg Richard A., Method of making crosslinked polymer matrices in tissue treatment applications.
  85. Zsebo, Krisztina M.; Bosselman, Robert A.; Suggs, Sidney V.; Martin, Francis H., Method of stimulating growth of melanocyte cells by administering stem cell factor.
  86. Eaton, Dan L.; De Sauvage, Frederic J., Method of treatment of thrombocytopenia or risk thereof using MPL ligand (thrombopoietin), variants, and fragments thereof.
  87. Rhee Woonza M. ; DeLustro Frank A. ; Berg Richard A., Method of using crosslinked polymer compositions in tissue treatment applications.
  88. Rosario-Jansen, Theresa; Wright, David Erick, Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy.
  89. Hartman, Jacob; Mendelovitz, Simona; Rehrig, Claudia D.; Huang, William; Hershfield, Michael, Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase.
  90. DeFrees, Shawn; Kinealy, Kyle, Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography.
  91. Sehl, Louis C.; Trollsas, Olof Mikael; Wallace, Donald G.; Toman, David; DeLustro, Frank A.; Schroeder, Jacqueline A.; Chu, George H., Methods for tissue repair using adhesive materials.
  92. Xu, Wenfeng; Kindsvogel, Wayne R.; Chandrasekher, Yasmin A.; Dillon, Stacey R.; Lehner, Joyce M.; Siadak, Anthony W.; Sivakumar, Pallavur V.; Moore, Margaret D., Methods of producing anti-IL-22RA antibodies.
  93. Kindsvogel, Wayne R.; Topouzis, Stavros, Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors.
  94. Vanessa Hsei ; Iphigenia Koumenis ; Steven Leong ; Leonard Presta ; Zahra Shahrokh ; Gerardo Zapata, Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugates.
  95. Vanessa Hsei ; Iphigenia Koumenis ; Steven Leong ; Leonard Presta ; Zahra Shahrokh ; Gerardo Zapata, Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates.
  96. Xu, Wenfeng; Kindsvogel, Wayne R.; Chandrasekher, Yasmin A.; Dillon, Stacey R.; Lehner, Joyce M.; Siadak, Anthony W.; Sivakumar, Pallavur V.; Moore, Margaret Dow, Methods of treatment using anti-IL-22RA antibodies.
  97. Zopf, David A.; Lubenau, Heinz, Methods of treatment using glycopegylated G-CSF.
  98. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P., Methods of using OSK1 peptide analogs.
  99. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  100. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  101. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  102. Feige,Ulrich, Modified peptides as therapeutic agents.
  103. Bartley Timothy D. ; Bogenberger Jakob M. ; Bosselman Robert A. ; Hunt Pamela ; Kinstler Olaf B. ; Samal Babru B., Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation.
  104. Eaton, Dan L.; de Sauvage, Frederic J., Monoclonal antibody to human thrombopoietin.
  105. Eaton, Dan L.; de Sauvage, Frederic J., Mpl ligand (thrombopoietin), nucleic acids encoding such, and methods of treatment using mpl ligand.
  106. Gabriel,Nancy E.; Farrar,Christine E., N-terminally chemically modified protein compositions and methods.
  107. Kinstler, Olaf B., N-terminally chemically modified protein compositions and methods.
  108. Kinstler, Olaf B.; Gabriel, Nancy Elise; Farrar, Christine E.; DePrince, Randolph B., N-terminally chemically modified protein compositions and methods.
  109. Kinstler, Olaf B.; Gabriel, Nancy Elise; Farrar, Christine E.; DePrince, Randolph B., N-terminally chemically modified protein compositions and methods.
  110. Ladner Martha B. ; Van Arsdell Janelle N. ; Martin George A. ; Kawasaki Ernest S. ; Coyne Mazie Yee ; Halenbeck Robert F. ; Koths Kirston E., N.gradient.2 CSF-1 (short form) and carboxy truncated fragments thereof.
  111. Ladner Martha B. ; Noble Janelle A. ; Martin George A. ; Kawasaki Ernest S. ; Coyne Mazie Yee ; Halenbeck Robert F. ; Koths Kirston E., N.gradient.2-CSF-1(long form) and carboxy truncated fragments thereof.
  112. Eaton, Dan L.; De Sauvage, Frederic J., Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof.
  113. Brewer, Michael T.; Thompson, Robert C.; Kohno, Tadahiko, Nucleic acids encoding TNF inhibitor and method of production.
  114. Fisher, Eric; Edwards, III, Carl; Kieft, Gary, Nucleic acids encoding truncated soluble tumor necrosis factor.
  115. Felo, Michael; DeFrees, Shawn, Nucleotide sugar purification using membranes.
  116. DeFrees, Shawn; Zopf, David A.; Wang, Zhi-Guang; Clausen, Henrik, O-linked glycosylation of peptides.
  117. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P., OSK1 peptide analogs and pharmaceutical compositions.
  118. DeFrees, Shawn; Zopf, David A.; Taudte, Susann; Willett, Walter Scott; Bayer, Robert J.; Kalo, Matthew, One pot desialylation and glycopegylation of therapeutic peptides.
  119. Williams, L. David; Hershfield, Michael S.; Kelly, Susan J.; Saifer, Mark G. P.; Sherman, Merry R., PEG-urate oxidase conjugates and use thereof.
  120. Williams, L. David; Hershfield, Michael S.; Kelly, Susan J.; Saifer, Mark G. P.; Sherman, Merry R., PEG-urate oxidase conjugates and use thereof.
  121. Williams, L. David; Hershfield, Michael S.; Kelly, Susan J.; Saifer, Mark G. P.; Sherman, Merry R., PEG-urate oxidase conjugates and use thereof.
  122. Williams, L. David; Hershfield, Michael S.; Kelly, Susan J.; Saifer, Mark G. P.; Sherman, Merry R., PEG-urate oxidase conjugates and use thereof.
  123. Williams, L. David; Hershfield, Michael S.; Kelly, Susan J.; Saifer, Mark G. P.; Sherman, Merry R., PEG-urate oxidase conjugates and use thereof.
  124. Thompson, Robert C.; Brewer, Michael T.; Kohno, Tadahiko, PEGylation reagents and compounds formed therewith.
  125. Desnoyers,Luc; Filvaroff,Ellen; Goddard,Audrey; Godowski,Paul J.; Gurney,Austin L.; Wood,William I., PRO526 nucleic acids.
  126. Klausen, Niels Kristian; Bjorn, Soren; Behrens, Carsten; Garibay, Patrick William, Pegylated factor VII glycoforms.
  127. Orlando, Michele; Hemberger, Jurgen; Delbos Krampe, Jeanne, Pharmaceutically active oligosaccharide conjugates.
  128. Ladner Martha B. ; Noble Janelle A. ; Martin George A. ; Kawasaki Ernest S. ; Coyne Mazie Yee ; Halenbeck Robert F. ; Koths Kirston E., Point mutants of N.gradient.2 CSF-1 and carboxy truncated fragments thereof.
  129. Breitenkamp, Kurt; Sill, Kevin N.; Skaff, Habib, Poly(ethylene glycol) containing chemically disparate endgroups.
  130. Breitenkamp, Kurt; Sill, Kevin; Skaff, Habib, Poly(ethylene glycol) containing chemically disparate endgroups.
  131. Sill, Kevin N.; Skaff, Habib; Breitenkamp, Kurt, Poly(ethylene glycol) containing chemically disparate endgroups.
  132. Hakimi John ; Kilian Patricia ; Rosen Perry, Polyethylene-protein conjugates.
  133. Hakimi John ; Kilian Patricia ; Rosen Perry, Polyethylene-protein conjugates.
  134. Hakimi John ; Kilian Patricia ; Rosen Perry, Polyethylene-protein conjugates.
  135. Hakimi John ; Kilian Patricia ; Rosen Perry, Polyethylene-protein conjugates.
  136. Hakini John (Scarsdale NY) Kilian Patricia (Upper Montclair NJ) Rosen Perry (North Caldwell NJ), Polyethylene-protein conjugates.
  137. Pepinsky, Blake; Runkel, Laura; Brickelmaier, Margot; Whitty, Adrian; Hochman, Paula, Polymer conjugates of interferon beta-1A and uses.
  138. Pepinsky,Blake; Runkel,Laura; Brickelmaier,Margot; Whitty,Adrian; Hochman,Paula, Polymer conjugates of interferon beta-1A and uses.
  139. Saifer, Mark G. P.; Martinez, Alexa L.; Williams, L. David; Sherman, Merry R., Polymer conjugates of interferon-beta with enhanced biological potency.
  140. Kausch, Annemie Rehor; Cerritelli, Simona, Polymeric tissue sealant.
  141. Rehor, Annemie; Cerritelli, Simona, Polymeric tissue sealant.
  142. Fukuchi,Naoyuki; Kageyama,Shunsuke; Kito,Morikazu; Kayahara,Takashi; Yamamoto,Hiroshi, Process for producing subunit peptide originating in polymer protein.
  143. DeFrees, Shawn; Bowe, Caryn, Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography.
  144. DeFrees, Shawn; Zopf, David; Bayer, Robert; Hakes, David; Chen, Xi, Protein remodeling methods and proteins/peptides produced by the methods.
  145. Fischer, Meir; Harosh, Eliyahu, Purification of proteins with cationic surfactant.
  146. DeFrees, Shawn, Remodeling and glycopegylation of fibroblast growth factor (FGF).
  147. Zsebo,Krisztina M.; Bosselman,Robert A.; Suggs,Sidney V.; Martin,Francis H., SCF antibody compositions and methods of using the same.
  148. Daley Michael Joseph ; Buckwalter Brian Lee ; Cady Susan Mancini ; Shieh Hong-Ming ; Bohlen Peter ; Seddon Andrew P., Stabilization of fibroblast growth factors by modification of cysteine residues.
  149. Daley Michael Joseph ; Buckwalter Brian Lee ; Cady Susan Mancini ; Shieh Hong-Ming ; Bohlen Peter ; Seddon Andrew P., Stabilization of somatotropins and other proteins by modification of cysteine residues.
  150. Dave Kirti I. ; Botyanszki Janos ; Sintar Eva, Stabilized conjugates of uncomplexed subunits of multimeric proteins.
  151. Kirti I. Dave ; Janos Botyanszki ; Eva Sintar, Stabilized conjugates of uncomplexed subunits of multimeric proteins.
  152. Zsebo Krisztina M. ; Bosselman Robert A. ; Suggs Sidney V. ; Martin Francis H., Stem cell factor.
  153. Zsebo Krisztina M. ; Bosselman Robert A. ; Suggs Sidney V. ; Martin Francis H., Stem cell factor and compositions.
  154. Zsebo, Krisztina M.; Bosselman, Robert A.; Suggs, Sidney V.; Martin, Francis H., Stem cell factor compositions.
  155. Rhee, Woonza M.; DeLustro, Frank A.; Berg, Richard A., Synthetic implant with nonimmunogenicity coating.
  156. Hauptmann,Rudolf; Himmler,Adolf; Maurer Fogy,Ingrid; Stratowa,Christian, TNF receptors, TNF binding proteins and DNAs coding for them.
  157. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Colin V.; McDonough, Stefan I., Toxin peptide therapeutic agents.
  158. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Colin V.; McDonough, Stefan I., Toxin peptide therapeutic agents.
  159. Fisher,Eric F.; Edwards, III,Carl K.; Kieft,Gary L., Truncated soluble tumor necrosis factor type-I and type-II receptors.
  160. Gentz,Reiner L.; Ebner,Reinhard; Yu,Guo Liang; Ruben,Steven M.; Ni,Jian; Feng,Ping, Tumor necrosis factor 6α and 6β.
  161. Gentz,Reiner L.; Ebner,Reinhard; Yu,Guo Liang; Ruben,Steven M.; Ni,Jian; Feng,Ping, Tumor necrosis factor receptors 6α & 6β.
  162. Gentz, Reiner L.; Ebner, Reinhard; Yu, Guo-Liang; Ruben, Steven M.; Ni, Jian; Feng, Ping, Tumor necrosis factor receptors 6α and 6β.
  163. Hershfield,Michael; Kelly,Susan J., Urate oxidase.
  164. Ralph Peter ; Chong Kong T. ; Devlin James ; Zimmerman Robert ; Aukerman Sharon Lea ; Ring David B. ; Ma Sylvia Hsieh, Use of CSF-1 to treat tumor burden.
  165. Ralph Peter ; Chong Kong T., Uses of recombinant colony stimulating factor-1.
  166. Stefano, James; Pan, Clark; Qiu, Huawei; O'Callaghan, Michael; Matthews, Gloria, VEGF antagonist compositions and uses thereof.
  167. Hartman, Jacob; Mendelovitz, Simona, Variant form of urate oxidase and use thereof.
  168. Hartman, Jacob; Mendelovitz, Simona, Variant form of urate oxidase and use thereof.
  169. Hartman, Jacob; Mendelovitz, Simona, Variant form of urate oxidase and use thereof.
  170. Hartman, Jacob; Mendelovitz, Simona, Variant form of urate oxidase and use thereof.
  171. Hartman, Jacob; Mendelovitz, Simona, Variant form of urate oxidase and use thereof.
  172. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  173. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  174. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  175. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  176. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  177. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  178. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  179. Eaton, Dan L.; De Sauvage, Frederic J., mpl ligand.
  180. Eaton, Dan L.; De Sauvage, Frederic J., mpl ligand (thrombopoietin), active fragments thereof, and fusion proteins and compositions comprising mpl ligand and other cytokines.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로